2023 might just be the toughest year yet for medtech startups.
Public markets are down, venture capital is more hesitant than ever after making staggering losses in 2022 and now more...
AI Medical Technology Doubles Down On Melanoma With Trials And Financing
Over the past month, the company has released positive clinical trial results and raised more cash, both of which will help on its way to combat melanoma.
